Lilac Biosciences names Adriana Coll De Peña, Ph.D., CEO
Lilac Biosciences Inc. announced that Adriana Coll De Peña, Ph.D., joined the company on September 15, 2026, as chief executive officer. The company said the new CEO will grow the ModQuantTM platform beyond its first RNA modification kit into a broader set of RNA tools for research and therapeutic discovery.
Primary source
Company press release (PR Newswire), November 5, 2026
Lilac Biosciences Names Adriana Coll De Peña, Ph.D., Chief Executive Officer to Bring Fast, Quantitative RNA Measurement to Every Lab
Machine-summarized from the source above; not independently reported. How we use automation